Stoke Therapeutics, Inc. (STOK) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US86150R1077
Stoke Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 184.42 m USD |
| Operating income | -20.59 m USD |
| EBIT | -20.64 m USD |
| Net income | -6.89 m USD |
| Diluted EPS – continuing operations | -0.12 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase 3 clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
More stocks
- Zhejiang Runtu Co Ltd (002440.SZ)
- Ningbo ZhongDa Leader Intelligent Transmission Co Ltd (002896.SZ)
- Austevoll Seafood ASA (AUSS.OL)
- Vivendi SE (VIV.PA)
- BGF Retail Co Ltd (282330.KS)
- Personalis, Inc. (PSNL)
- GLOBAL INDUSTRIAL Co (GIC)
- Hoist Finance AB (publ) (HOFI.ST)
- Grupo Lamosa S.A.B. de C.V (LAMOSA.MX)
- Shenzhen Bluetrum Technology Co. Ltd. A (688332.SS)
- Lotte Shopping (023530.KS)
- Travis Perkins PLC (TPK.L)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.